fluoxetine has been researched along with Hypergonadotropic Hypogonadism in 1 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypogonadotropic hypogonadism is a major characteristic of patients with PWS, and it is speculated to be due to hypothalamic insufficiency." | 5.29 | Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. ( Clayton, AH; O'Donnell, T; Shaw, HA; Warnock, JK, 1995) |
| "Hypogonadotropic hypogonadism is a major characteristic of patients with PWS, and it is speculated to be due to hypothalamic insufficiency." | 1.29 | Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine. ( Clayton, AH; O'Donnell, T; Shaw, HA; Warnock, JK, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warnock, JK | 1 |
| Clayton, AH | 1 |
| Shaw, HA | 1 |
| O'Donnell, T | 1 |
1 other study available for fluoxetine and Hypergonadotropic Hypogonadism
| Article | Year |
|---|---|
Onset of menses in two adult patients with Prader-Willi syndrome treated with fluoxetine.
Topics: Adult; Age of Onset; Female; Fluoxetine; Follow-Up Studies; Gonadotropin-Releasing Hormone; Humans; | 1995 |